Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds
- PMID: 2783121
- DOI: 10.1016/0006-291x(89)92293-6
Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds
Abstract
Herbimycin A, an antibiotic which reverses Rous sarcoma virus transformation, inhibited irreversibly the auto- and trans-phosphorylation activities of p60v-src in in vitro immune complex kinase assays. The addition of a sulfhydryl compound such as dithiothreitol, 2-mercaptoethanol, glutathione (reduced form) or cysteine abolished the ability of herbimycin A to inactivate p60v-src kinase as well as the ability to reverse transformed cell morphology, whereas the addition of oxidized glutathione, cystine or methionine showed no effect. The sulfhydryl alkylating reagent N-ethylmaleimide also, although less effectively, inactivated p60v-src kinase activity in vitro. These results suggest the likelihood that sulfhydryl groups of p60v-src are involved in the inactivation of v-src tyrosine kinase activity by herbimycin A.
Similar articles
-
Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.Biochem Pharmacol. 1991 Oct 9;42(9):1661-71. doi: 10.1016/0006-2952(91)90500-5. Biochem Pharmacol. 1991. PMID: 1656993
-
Effects of herbimycin A and various SH-reagents on p60v-src kinase activity in vitro.Biochem Biophys Res Commun. 1990 Nov 30;173(1):276-82. doi: 10.1016/s0006-291x(05)81053-8. Biochem Biophys Res Commun. 1990. PMID: 2175179
-
Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.FEBS Lett. 1994 Mar 7;340(3):155-8. doi: 10.1016/0014-5793(94)80127-4. FEBS Lett. 1994. PMID: 8131836
-
Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.Exp Cell Res. 1991 Aug;195(2):338-44. doi: 10.1016/0014-4827(91)90382-5. Exp Cell Res. 1991. PMID: 2070817
-
New insight into oncoprotein-targeted antitumor effect: herbimycin A as an antagonist of protein tyrosine kinase against Ph1-positive leukemia cells.Leuk Lymphoma. 1993 Dec;12(1-2):41-9. doi: 10.3109/10428199309059570. Leuk Lymphoma. 1993. PMID: 8161936 Review.
Cited by
-
Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.J Cell Biol. 1992 Nov;119(4):893-903. doi: 10.1083/jcb.119.4.893. J Cell Biol. 1992. PMID: 1385444 Free PMC article.
-
Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line.J Cell Biol. 1997 Jul 28;138(2):449-69. doi: 10.1083/jcb.138.2.449. J Cell Biol. 1997. PMID: 9230085 Free PMC article.
-
Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):63-8. doi: 10.1042/bj3010063. Biochem J. 1994. PMID: 8037692 Free PMC article.
-
Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells.Mol Biol Cell. 1994 Mar;5(3):349-61. doi: 10.1091/mbc.5.3.349. Mol Biol Cell. 1994. PMID: 8049526 Free PMC article.
-
Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.Immunology. 1993 Feb;78(2):210-7. Immunology. 1993. PMID: 7682535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous